中文 | English
Return
Total: 467 , 1/47
Show Home Prev Next End page: GO
Author:( Lili Zhou)

1.Discussion on effect and proper time of enteroclysis in treating chronic renal failure

Lili ZHOU ; Ning ZHANG

China Journal of Traditional Chinese Medicine and Pharmacy 2005;0(08):-

2.Infections and Antibiotic Resistance of Ureaplasma Urealytium and Mycoplasma Hominis in Huangshi Area

Lili ZHOU ; Yongqiang DUAN

China Pharmacy 2001;0(08):-

3.Damage to the central noradrenergic system and changes of P3-like cognitive potential in rats

Yuechun WANG ; Lili ZHOU

Chinese Journal of Tissue Engineering Research 2005;9(13):196-198

4.Clinical effect of mifepristone combined with misoprostol for termination of pregnancy in high risk pregnant women

Lili SHI ; Wuying ZHOU

Chinese Journal of Primary Medicine and Pharmacy 2016;23(20):3098-3101

5.Comparison of clinical and coronary angiographic characteristics in acute myocardial infarction patients with new-onset atrial fibrillation in early or later stages

Lili LIU ; Lijun WANG ; Jing ZHOU

Chinese Journal of Interventional Cardiology 2014;(6):365-368

6.Cervical HPV infection and genotype distribution characteristics in women with vaginal disease

Xionghui LIN ; Changshao ZHOU ; Lili CHEN

Chinese Journal of Biochemical Pharmaceutics 2016;36(11):183-185

7.Expression and significance of clusterin in prostate neoplasm

Liqun ZHOU ; Xuezhen YANG ; Lili LIANG

Chinese Journal of Urology 2001;0(03):-

8.Immune mechanical study of total glycoside from Cornus officinalis against rheumatoid arthritis

Lili GUO ; Yong ZHOU ; Xudan WANG

Chinese Journal of Immunology 1985;0(03):-

9.Expression of dihydrodiol dehydrogenase 2 in prostate cancer and its significance

Weidong SONG ; Liqun ZHOU ; Lili LIANG

Chinese Journal of Urology 2001;0(09):-

10.Study on the Tumor Targeting of RGD-PEG-liposomes

Zhanshan LI ; Jiping ZHOU ; Lili WANG

China Pharmacy 2001;0(07):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 467 , 1/47 Show Home Prev Next End page: GO